AI Medical Service Inc. Signs Joint Research Agreement with Mahidol University in Thailand
Retrieved on:
Monday, April 22, 2024
Hardware, Data Management, Start-Up, Technology, University, Surgery, Education, Oncology, Professional Services, Medical Devices, Hospitals, Artificial Intelligence, Science, Software, Research, Health, Mahidol University, Cancer, Esophageal cancer, Survival, AIM, Veterinary medicine, Humanities, Stomach, Engineering, Mahidol Adulyadej, Medicine, Biopsy, Multimedia, Marketing, Diagnosis, Death, Quality of life, Comment, Medical device
AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, signed a joint research agreement with Mahidol University in Thailand (hereinafter Mahidol) on March 1, 2024, and began research activities on April 1, 2024.
Key Points:
- AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, signed a joint research agreement with Mahidol University in Thailand (hereinafter Mahidol) on March 1, 2024, and began research activities on April 1, 2024.
- AIM is the first Japanese company to sign a joint research agreement with Mahidol in the field of endoscopic AI, and Mahidol is the first Thai institute that AIM has collaborated with thus far1.
- View the full release here: https://www.businesswire.com/news/home/20240418278652/en/
AIM has initiated joint research with Mahidol to assess the practicality of its endoscopic AI. - Collaboration with Mahidol will facilitate joint research designed to test the applicability of Japanese endoscopic AI in Thailand.